Factors affecting self-efficacy and pain intensity in patients with chronic musculoskeletal pain seen in a specialist rheumatology pain clinic

Rheumatology

Volumn 47, Issue 12, 2008, Pages 1803-1808

  Rahman, Anisur ^a   Reed, E ^a   Underwood, M ^b   Shipley, M E ^a   Omar, R Z ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Chronic musculoskeletal pain; Pain clinic; Self efficacy

Indexed keywords

ADULT; ARTICLE; CHIROPRACTIC; CHRONIC PAIN; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL PAIN; OSTEOPATHIC MEDICINE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAIN THRESHOLD; PHYSIOTHERAPY; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOLOGY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SELF CONCEPT; SOCIAL PSYCHOLOGY; SYMPTOM; TREATMENT DURATION;

ADAPTATION, PSYCHOLOGICAL; ADULT; CHRONIC DISEASE; DEPRESSION; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASES; PAIN; PAIN CLINICS; PAIN MEASUREMENT; PROGNOSIS; SELF EFFICACY; TREATMENT OUTCOME; UNEMPLOYMENT;

EID: 56649113049     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken377     Document Type: Article

References (38)

1. Bergman S, Herrstrom P, Jacobsson LT, Petersson IF. Chronic widespread pain: A three year followup of pain distribution and risk factors. J Rheumatol 2002;29: 818-25.
2. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
3. MacFarlane GJ, Thomas E, Papageorgiou AC, Schollum J, Croft PR, Silman AJ. The natural history of chronic pain in the community: A better prognosis than in the clinic? J Rheumatol 1996;23:1617-20.
4. Papageorgiou AC, Silman AJ, Macfarlane GJ. Chronic widespread pain in the population: A seven year follow up study. Ann Rheum Dis 2002;61:1071-4.
5. Andersson HI, Ejlertsson G, Leden I, Rosenberg C. Characteristics of subjects with chronic pain, in relation to local and widespread pain report. A prospective study of symptoms, clinical findings and blood tests in subgroups of a geographically defined population. Scand J Rheumatol 1996;25:146-54.
6. Buskila D, Abramov G, Biton A, Neumann L. The prevalence of pain complaints in a general population in Israel and its implications for utilization of health services. J Rheumatol 2000;27:1521-5.
7. Parsons S, Breen A, Foster N et al. Prevalence and comparative troublesomeness by age of musculoskeletal pain in different body locations. Fam Pract 2007;24: 308-16.
8. Rohrbeck J, Jordan K, Croft P. The frequency and characteristics of chronic widespread pain in general practice: A case-control study. Br J Gen Pract 2007;57:109-15.
9. Ledingham J, Doherty S, Doherty M. Primary fibromyalgia syndrome - an outcome study. Br J Rheumatol 1993;32:139-42.
10. Bergman S, Herrstrom P, Hogstrom K, Petersson IF, Svensson B, Jacobsson LT. Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study. J Rheumatol 2001;28:1369-77.
11. McBeth J, Macfarlane GJ, Benjamin S, Silman AJ. Features of somatization predict the onset of chronic widespread pain: Results of a large population-based study. Arthritis Rheum 2001;44:940-6.
12. McBeth J, Macfarlane GJ, Hunt IM, Silman AJ. Risk factors for persistent chronic widespread pain: A community-based study. Rheumatology 2001;40:95-101.
13. Gupta A, Silman AJ, Ray D et al. The role of psychosocial factors in predicting the onset of chronic widespread pain: Results from a prospective population-based study. Rheumatology 2007;46:666-71.
14. Underwood MR, Morton V, Farrin A. Do baseline characteristics predict response to treatment for low back pain? Secondary analysis of the UK BEAM dataset [ISRCTN32683578]. Rheumatology 2007;46:1297-302.
15. Rahman A, Ambler G, Underwood MR, Shipley ME. Important determinants of self-efficacy in patients with chronic musculoskeletal pain. J Rheumatol 2004;31:1187-92.
16. Harding G, Parsons S, Rahman A, Underwood M. "It struck me that they didn't understand pain": The specialist pain clinic experience of patients with chronic musculoskeletal pain. Arthritis Rheum 2005;53:691-6.
17. Bandura A. Self-efficacy: Toward a unifying theory of behavioral change. Psychol Rev 1977;84:191-215.
18. Arnstein P, Caudill M, Mandle CL, Norris A, Beasley R. Self efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients. Pain 1999;80:483-91.
19. Asghari A, Nicholas MK. Pain self-efficacy beliefs and pain behaviour. A prospective study. Pain 2001;94:85-100.
20. Strong J, Westbury K, Smith G, McKenzie I, Ryan W. Treatment outcome in individuals with chronic pain: Is the Pain Stages of Change Questionnaire (PSOCQ) a useful tool? Pain 2002;97:65-73.
21. Foster G, Taylor SJ, Eldridge SE, Ramsay J, Griffiths CJ. Self-management education programmes by lay leaders for people with chronic conditions. Cochrane Database Syst Rev 2007:CD005108.
22. Nicholas MK. The pain self-efficacy questionnaire: Taking pain into account. Eur J Pain 2007;11:153-63.
23. Leveille SG, Ling S, Hochberg MC et al. Widespread musculoskeletal pain and the progression of disability in older disabled women. Ann Intern Med 2001;135:1038-46.
24. White KP, Nielson WR, Harth M, Ostbye T, Speechley M. Chronic widespread musculoskeletal pain with or without fibromyalgia: Psychological distress in a representative community adult sample. J Rheumatol 2002;29:588-94.
25. Nicholas MK, Wilson PH, Goyen J. Comparison of cognitive-behavioral group treatment and an alternative non-psychological treatment for chronic low back pain. Pain 1992;48:339-47.
26. Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 2005;52:2495-505.
27. Gendreau RM, Thorn MD, Gendreau JF et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005;32:1975-85.
28. Arnold LM, Goldenberg DL, Stanford SB et al. Gabapentin in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 2007;56:1336-44.
29. Crofford LJ, Rowbotham MC, Mease PJ et al. Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:1264-73.
30. Ferraz MB, Quaresma MR, Aquino LR, Atra E, Tugwell P, Goldsmith CH. Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol 1990;17:1022-4.
31. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain 1992;50:133-49.
32. Harvey E, Burton AK, Moffett JK, Breen A. Spinal manipulation for low-back pain: A treatment package agreed to by the UK chiropractic, osteopathy and physiotherapy professional associations. Man Ther 2003;8:46-51.
33. Machin D, Campbell MJ. Design of studies for medical research. Chichester: John Wiley and Sons, 2005.
34. Omar RZ, Wright EM, Turner RM, Thompson SG. Analysing repeated measurements data: A practical comparison of methods. Stat Med 1999;18:1587-603.
35. van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999;18:681-94.
36. Foster NE, Pincus T, Underwood MR, Vogel S, Breen A, Harding G. Understanding the process of care for musculoskeletal conditions - why a biomedical approach is inadequate. Rheumatology 2003;42:401-4.
37. Hunt IM, Silman AJ, Benjamin S, McBeth J, Macfarlane GJ. The prevalence and associated features of chronic widespread pain in the community using the 'Manchester' definition of chronic widespread pain. Rheumatology 1999;38:275-9.
38. Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.